| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 105 |
| 1 | RANITIDINE | 72 |
| 2 | ADALIMUMAB | 66 |
| 3 | METHOTREXATE SODIUM | 53 |
| 4 | METHOTREXATE | 46 |
| 5 | AZATHIOPRINE | 37 |
| 6 | RANITIDINE HYDROCHLORIDE | 33 |
| 7 | PREDNISONE | 31 |
| 8 | RITONAVIR | 31 |
| 9 | ETANERCEPT | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RETIFANLIMAB-DLWR | 5 | 0.0694 |
| 1 | OXYCODONE AND ASPIRIN | 2 | 0.0392 |
| 2 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 3 | CASTOR OIL | 1 | 0.0052 |
| 4 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 5 | MARAVIROC | 8 | 0.0035 |
| 6 | RALTEGRAVIR | 17 | 0.0032 |
| 7 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 8 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 9 | DORAVIRINE | 2 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 8 | 0.0035 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0011 |
| 2 | Protease Inhibitor [EPC] | 43 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 43 | 0.0007 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0005 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 52 | 0.0005 |
| 8 | Aminosalicylate [EPC] | 42 | 0.0004 |
| 9 | Purine Antimetabolite [EPC] | 37 | 0.0004 |